Fulgent Genetics, Inc. FLGT Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue by Business | |||||
| Laboratory Services | $322.22M+13.7% | $283.47M-2.0% | $289.21M-53.3% | $618.97M-37.6% | |
| Therapeutic Development | $447K— | $0— | $0— | $0— | |
| Revenue by Geography | |||||
| Non Us | $26.12M+1.9% | $25.64M+26.7% | $20.24M+27.9% | $15.82M+16.3% | |
| Other Countries | $13.21M+1.6% | $13.01M+48.0% | $8.79M+27.7% | $6.88M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Fulgent Genetics, Inc. break its business down?
- Fulgent Genetics, Inc. (FLGT) reports revenue by business across 2 parts — Laboratory Services and Therapeutic Development. Each is extracted from the segment footnotes and tracked over time.
- Where does Fulgent Genetics, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Fulgent Genetics, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
